Research

• Select this article
  • M Cives,
  • P L Kunz,
  • B Morse,
  • D Coppola,
  • M J Schell,
  • T Campos,
  • P T Nguyen,
  • P Nandoskar,
  • V Khandelwal,
  • and J R Strosberg

  Phase II clinical trial of pasireotide long-acting repeatable in patients with metastatic neuroendocrine tumors

  Endocr Relat Cancer 22 (1) 1-9, doi:10.1530/ERC-14-0360 first published on 6 November 2014
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only
• Select this article
  • Aparna Lakshmanan,
  • Anna Wojcicka,
  • Marta Kotlarek,
  • Xiaoli Zhang,
  • Krystian Jazdzewski,
  • and Sissy M Jhiang

  microRNA-339-5p modulates Na⁺/I⁻ symporter-mediated radioiodide uptake

  Endocr Relat Cancer 22 (1) 11-21, doi:10.1530/ERC-14-0439 first published on 17 November 2014
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only
• Select this article
  • Jie Cai,
  • Lin Li,
  • Lei Ye,
  • Xiaohua Jiang,
  • Liyun Shen,
  • Zhibo Gao,
  • Weiyuan Fang,
  • Fengjiao Huang,
  • Tingwei Su,
  • Yulin Zhou,
  • Weiqing Wang,
  • and Guang Ning

  Exome sequencing reveals mutant genes with low penetrance involved in MEN2A-associated tumorigenesis

  Endocr Relat Cancer 22 (1) 23-33, doi:10.1530/ERC-14-0225 first published on 17 November 2014
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only
  • Supplementary Data
• Select this article
  • Nora Sahnane,
  • Daniela Furlan,
  • Matilde Monti,
  • Chiara Romualdi,
  • Alessandro Vanoli,
  • Emanuela Vicari,
  • Enrico Solcia,
  • Carlo Capella,
  • Fausto Sessa,
  • and Stefano La Rosa

  Microsatellite unstable gastrointestinal neuroendocrine carcinomas: a new clinicopathologic entity

  Endocr Relat Cancer 22 (1) 35-45, doi:10.1530/ERC-14-0410 first published on 2 December 2014
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only
  • Supplementary Data
• Select this article
  • Fabio R Faucz,
  • Anelia D Horvath,
  • Monalisa F Azevedo,
  • Isaac Levy,
  • Beata Bak,
  • Ying Wang,
  • Paraskevi Xekouki,
  • Eva Szarek,
  • Evgenia Gourgari,
  • Allison D Manning,
  • Rodrigo Bertollo de Alexandre,
  • Emmanouil Saloustros,
  • Giampaolo Trivellin,
  • Maya Lodish,
  • Paul Hofman,
  • Yvonne C Anderson,
  • Ian Holdaway,
  • Edward Oldfield,
  • Prashant Chittiboina,
  • Maria Nesterova,
  • Nienke R Biermasz,
  • Jan M Wit,
  • Daniel J Bernard,
  • and Constantine A Stratakis

  Is IGSF1 involved in human pituitary tumor formation?

  Endocr Relat Cancer 22 (1) 47-54, doi:10.1530/ERC-14-0465
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only
  • Supplementary Data
• Select this article
  • Gahee Park,
  • Tae Hyuk Kim,
  • Hae-Ock Lee,
  • Jung Ah Lim,
  • Jae-Kyung Won,
  • Hye Sook Min,
  • Kyu Eun Lee,
  • Do Joon Park,
  • Young Joo Park,
  • and Woong-Yang Park

  Standard immunohistochemistry efficiently screens for anaplastic lymphoma kinase rearrangements in differentiated thyroid cancer

  Endocr Relat Cancer 22 (1) 55-63, doi:10.1530/ERC-14-0467
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only
  • Supplementary Data
• Select this article
  • Rodrigo A Toledo,
  • Roxanne Hatakana,
  • Delmar M Lourenço, Jr,
  • Susan C Lindsey,
  • Cleber P Camacho,
  • Marcio Almeida,
  • José V Lima, Jr,
  • Tomoko Sekiya,
  • Elena Garralda,
  • Michel S Naslavsky,
  • Guilherme L Yamamoto,
  • Monize Lazar,
  • Osorio Meirelles,
  • Tiago J P Sobreira,
  • Maria Lucia Lebrao,
  • Yeda A O Duarte,
  • John Blangero,
  • Mayana Zatz,
  • Janete M Cerutti,
  • Rui M B Maciel,
  • and Sergio P A Toledo

  Comprehensive assessment of the disputed RET Y791F variant shows no association with medullary thyroid carcinoma susceptibility

  Endocr Relat Cancer 22 (1) 65-76, doi:10.1530/ERC-14-0491 first published on 25 November 2014
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only
  • Supplementary Data

  OPEN ACCESS ARTICLE
• Select this article
  • Isabelle Laverdière,
  • Christine Flageole,
  • Étienne Audet-Walsh,
  • Patrick Caron,
  • Yves Fradet,
  • Louis Lacombe,
  • Éric Lévesque,
  • and Chantal Guillemette

  The UGT1 locus is a determinant of prostate cancer recurrence after prostatectomy

  Endocr Relat Cancer 22 (1) 77-85, doi:10.1530/ERC-14-0423 first published on 1 December 2014
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only
  • Supplementary Data
• Select this article
  • C Verdelli,
  • L Avagliano,
  • P Creo,
  • V Guarnieri,
  • A Scillitani,
  • L Vicentini,
  • G B Steffano,
  • E Beretta,
  • L Soldati,
  • E Costa,
  • A Spada,
  • G P Bulfamante,
  • and S Corbetta

  Tumour-associated fibroblasts contribute to neoangiogenesis in human parathyroid neoplasia

  Endocr Relat Cancer 22 (1) 87-98, doi:10.1530/ERC-14-0161 first published on 16 December 2014
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only
• Select this article
  • A R Glover,
  • J T Zhao,
  • J C Ip,
  • J C Lee,
  • B G Robinson,
  • A J Gill,
  • P S H Soon,
  • and S B Sidhu

  Long noncoding RNA profiles of adrenocortical cancer can be used to predict recurrence

  Endocr Relat Cancer 22 (1) 99-109, doi:10.1530/ERC-14-0457
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only
• Select this article
  • Misu Lee,
  • Amelie Lupp,
  • Nigel Mendoza,
  • Niamh Martin,
  • Rudi Beschorner,
  • Jürgen Honegger,
  • Jürgen Schlegel,
  • Talia Shively,
  • Elke Pulz,
  • Stefan Schulz,
  • Federico Roncaroli,
  • and Natalia S Pellegata

  SSTR3 is a putative target for the medical treatment of gonadotroph adenomas of the pituitary

  Endocr Relat Cancer 22 (1) 111-119, doi:10.1530/ERC-14-0472 first published on 16 December 2014
  • Abstract
  • Full Text
  • Full Text (PDF)
  • Figures Only
  • Supplementary Figure